Exploring genomic, metabolic, and proteomic data for heart, lung, and blood health.
Official title: NHLBI TRANS-OMICS FOR PRECISION MEDICINE (TOPMED) FOR THE CENTRALIZED OMICS RESOURCE (CORE) - TASK AREAS 2, 3, AND 4 - 2024 TASK ORDER
Funded at Broad Institute, INC. · NIH-11212875 · Data updated 2026-11-12
This study is looking at how our genes and other biological information can help us better understand heart, lung, and blood health, so that patients can get better tests and treatments tailored just for them.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Broad Institute, INC. NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project start | September 23, 2024 |
| Project end | September 22, 2025 |
| Funding year | 2024 |
| Award (this year) | $23,600,775 |
| NIH project number | 75N92023D00013-0-759202400001-1 |
| Project ID | NIH-11212875 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals with known heart, lung, or blood disorders who are willing to provide biological samples for analysis.
✕Less likely to help
Patients without any cardiovascular, pulmonary, or hematological conditions may not receive direct benefits from this research.
What this research studies
This research focuses on enhancing our understanding of heart, lung, and blood health by analyzing genomic, metabolic, and proteomic data from diverse patient cohorts. By collaborating with the Broad Institute, the project aims to leverage advanced technologies to characterize biological samples, which could lead to new insights into disease mechanisms. Patients may benefit from improved diagnostic tools and personalized treatment strategies based on their unique biological profiles.
Why it matters
Potential benefit: If successful, this research could lead to more precise and effective treatments for patients with heart, lung, and blood conditions.
How similar studies have gone: Previous research has shown success in using omics approaches to uncover new insights into complex diseases, indicating that this methodology is promising.
Where this research is happening
-
Broad Institute, INC.
Cambridge, United States Active
Researchers
- Principal investigator: Murphy, Bridget — Broad Institute, INC.
- Study coordinator: Murphy, Bridget
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.